Spots Global Cancer Trial Database for paclitaxel + carboplatin
Every month we try and update this database with for paclitaxel + carboplatin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC) | NCT02453282 | Non-Small-Cell ... | MEDI4736 (Durva... MEDI4736 (Durva... Paclitaxel + Ca... Gemcitabine + C... Gemcitabine + C... Pemetrexed + Ci... Pemetrexed + Ca... Tremelimumab | 18 Years - 130 Years | AstraZeneca | |
| Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL) | NCT03003962 | Non Small Cell ... | Durvalumab (MED... Paclitaxel + ca... Gemcitabine + c... Gemcitabine + c... Pemetrexed + ci... Pemetrexed + ca... | 18 Years - 130 Years | AstraZeneca | |
| Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC) | NCT00298415 | NSCLC | Paclitaxel + Ca... Monotherapy (ge... | 70 Years - 89 Years | Intergroupe Francophone de Cancerologie Thoracique | |
| A Randomized Controlled Trial of Neoadjuvant Weekly Paclitaxel Versus Weekly Paclitaxel Plus Weekly Carboplatin In Women With Large Operable or Locally Advanced, Triple Negative Breast Cancer | NCT03168880 | Triple Negative... | Paclitaxel + Ca... Paclitaxel only | 18 Years - 70 Years | Tata Memorial Hospital | |
| Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE) | NCT02542293 | Non Small Cell ... | Durvalumab +Tre... Paclitaxel + ca... Gemcitabine + c... Gemcitabine + c... Pemetrexed + ci... Pemetrexed + ca... | 18 Years - 130 Years | AstraZeneca | |
| Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE) | NCT02542293 | Non Small Cell ... | Durvalumab +Tre... Paclitaxel + ca... Gemcitabine + c... Gemcitabine + c... Pemetrexed + ci... Pemetrexed + ca... | 18 Years - 130 Years | AstraZeneca | |
| Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer | NCT00254891 | Carcinoma, Non-... | PF-3512676 + Pa... Paclitaxel + Ca... | 18 Years - | Pfizer | |
| Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL) | NCT03003962 | Non Small Cell ... | Durvalumab (MED... Paclitaxel + ca... Gemcitabine + c... Gemcitabine + c... Pemetrexed + ci... Pemetrexed + ca... | 18 Years - 130 Years | AstraZeneca | |
| A Randomized Controlled Trial of Neoadjuvant Weekly Paclitaxel Versus Weekly Paclitaxel Plus Weekly Carboplatin In Women With Large Operable or Locally Advanced, Triple Negative Breast Cancer | NCT03168880 | Triple Negative... | Paclitaxel + Ca... Paclitaxel only | 18 Years - 70 Years | Tata Memorial Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
